14-90873790-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_004755.4(RPS6KA5):c.2002C>A(p.Leu668Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000685 in 1,460,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_004755.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPS6KA5 | NM_004755.4 | c.2002C>A | p.Leu668Ile | missense_variant | 16/17 | ENST00000614987.5 | NP_004746.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPS6KA5 | ENST00000614987.5 | c.2002C>A | p.Leu668Ile | missense_variant | 16/17 | 1 | NM_004755.4 | ENSP00000479667 | P1 | |
RPS6KA5 | ENST00000536315.6 | c.1765C>A | p.Leu589Ile | missense_variant | 16/17 | 2 | ENSP00000442803 | |||
RPS6KA5 | ENST00000556178.5 | c.*1472C>A | 3_prime_UTR_variant, NMD_transcript_variant | 13/14 | 5 | ENSP00000451305 | ||||
RPS6KA5 | ENST00000648062.1 | c.*1628C>A | 3_prime_UTR_variant, NMD_transcript_variant | 18/19 | ENSP00000497354 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.85e-7 AC: 1AN: 1460086Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 726386
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.2002C>A (p.L668I) alteration is located in exon 16 (coding exon 16) of the RPS6KA5 gene. This alteration results from a C to A substitution at nucleotide position 2002, causing the leucine (L) at amino acid position 668 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.